Investigating the health effects of low-density malaria infections in children in Tanzania
Long-term health and socioeconomic impact of interventions targeting low-density malaria infection (LMI) among children in Tanzaniav
This study is looking at how low-density malaria infections, which can be hard to spot, affect the health and growth of children in Tanzania, so we can find better ways to help them grow up healthy and strong.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11065549 on NIH RePORTER |
What this research studies
This research focuses on understanding the long-term health and socioeconomic impacts of low-density malaria infections (LMI) among children in Tanzania. It aims to evaluate how these chronic infections, which often go undetected, affect children's health, growth, and cognitive development. The study will utilize advanced detection methods to identify LMI and assess the effectiveness of treatment strategies. By gathering data on the health consequences of LMI, the research seeks to inform better healthcare policies and practices for managing malaria in low-transmission settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years living in areas with low malaria transmission in Tanzania.
Not a fit: Patients who are not children or those living in high malaria transmission areas may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes for children suffering from low-density malaria infections.
How similar studies have performed: Previous research has shown that addressing low-density malaria infections can lead to significant health improvements, suggesting that this approach may be effective.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Hsiang, Michelle Sang — University of California, San Francisco
- Study coordinator: Hsiang, Michelle Sang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.